ABT-869 (Linifanib)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ABT-869 (Linifanib), covering 2013-04-29 to 2013-04-29. Get the full timeline:
Most recent: Clinical Trial Update: Study of Carboplatin/Paclitaxel in Combination With ABT-869 in Subjects With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) [Phase 2]